Acute nicotine enhances contextual fear conditioning, whereas withdrawal from chronic nicotine produces impairments. However, the nicotinic acetylcholine receptors (nAChR) that are involved in nicotine withdrawal deficits in contextual fear conditioning are unknown. The present study used genetic and pharmacological techniques to investigate the nAChR subtype(s) involved in the effects of nicotine withdrawal on contextual fear conditioning. b2 or a7 nAChR subunit knockout (KO) and corresponding wild-type (WT) mice were withdrawn from 12 days of chronic nicotine treatment (6.3 mg/kg/day), and trained with 2 conditioned stimulus (CS; 85 dB white noise)-unconditioned stimulus (US; 0.57 mA footshock) pairings on day 13. On day 14, mice were tested for contextual and cued freezing. b2 KO mice did not show nicotine withdrawal-related deficits in contextual fear conditioning, in contrast to WT mice and a7 KO mice. A follow-up study investigated if nicotine withdrawal disrupts acquisition or recall of contextual fear conditioning. The high affinity nAChR antagonist dihydro-b-erythroidine (DHbE; 3 mg/kg) was administered prior to training or testing to precipitate withdrawal in chronic nicotine-treated C57BL/6 mice. Deficits in contextual fear conditioning were observed in chronic nicotine-treated mice when DHbE was administered prior to training, but not when administered at testing. These results indicate that b2-containing nAChRs, such as the a4b2 receptor, mediate nicotine withdrawal deficits in contextual fear conditioning. In addition, nicotine withdrawal selectively affects acquisition but not recall or expression of the learned response.
Introduction
Cigarette smoking is a serious health problem in the United States: over 435,000 deaths each year are attributed to smoking (Mokdad, Marks, Stroup, & Gerberding, 2004) . Although 42% of smokers attempt to quit each year, less than 6% are successful, suggesting that current smoking cessation treatments are not adequate (McIlvain, Susman, Davis, & Gilbert, 1995) . The addictive liability of nicotine may relate to its ability to usurp the functioning of several processes, and to produce a range of withdrawal symptoms (see Baker, Brandon, & Chassin, 2004; Mansvelder, De Rover, McGehee, & Brussaard, 2003; Nestler, 2002 for review) . In order to develop more effective smoking cessation treatments, an understanding of the cellular mechanisms that underlie nicotine addiction is necessary.
In humans, disrupted cognition is frequently reported as a symptom of nicotine withdrawal (Hughes, Higgins, & Bickel, 1994; Jacobsen et al., 2005; Mendrek et al., 2006) . However, few animal studies have investigated the effects of nicotine withdrawal on learning and memory. Previously, we demonstrated differential effects of acute, chronic, and withdrawal from chronic nicotine on contextual fear conditioning in mice. Acute nicotine enhanced contextual fear conditioning; however, a dose of chronic nicotine that produced similar plasma nicotine levels [and was within the range observed in smokers (Benowitz, Porchet, & Jacob, 1989; Henningfield & Keenan, 1993) ] had no effect, suggesting the development of tolerance.
